In the quiet accumulation of modern life — the packaging, the cosmetics, the air itself — something invisible has been settling into the human body. Researchers at NYU Langone Health have now found microplastics embedded in the prostate tumors of nine out of ten cancer patients studied, with concentrations in cancerous tissue more than twice those found in healthy cells nearby. It is the first Western study to measure plastic particle buildup directly within prostate tumors, and it raises a question that science is only beginning to ask: whether the materials we have made our world from are qu
Microplastics Found in 90% of Prostate Tumors in NYU Study
Plastic in tumors was 2.5 times higher than in healthy tissue
Mark
So they found plastic in nine out of ten prostate tumors. That's a striking number. But what does it actually mean—does plastic cause cancer, or is it just there?
Mimi
That's the question the study can't answer yet. They found it concentrated more heavily in tumors than in healthy tissue, which suggests a connection. But this is a pilot study with only ten patients. They're presenting evidence of an association, not proof of causation.
Luke
Right. And we should be clear about what they measured. They looked at twelve common types of plastic molecules in tissue samples. They didn't track how those plastics got there, when they accumulated, or whether the patients with tumors had been exposed to more plastic than the control group. They're comparing tumor tissue to noncancerous tissue from the same person, which is useful, but it's not the same as comparing cancer patients to cancer-free people.
Mark
So what's the mechanism they think is at work?
Mimi
They're hypothesizing that microplastics might trigger inflammation in the tissue. Chronic inflammation can damage cells and cause genetic mutations that lead to cancer. But that's speculation at this point. They haven't tested it yet.
Luke
And inflammation is a pretty broad pathway. Lots of things cause inflammation. The fact that plastic particles are present doesn't tell us whether they're actually causing the inflammation, or whether they're just accumulating in tissue that's already inflamed for other reasons.
Mark
What about the exposure side? How much plastic are people actually ingesting or inhaling?
Mimi
That's largely unmeasured. We know microplastics are in food, water, air, and cosmetics. We know they're in human blood and organs. But there's no clear picture of dose—how much exposure is typical, how much is dangerous, whether it varies by age or lifestyle.
Luke
And that matters for interpreting this study. If everyone has microplastics in their prostate tissue, then finding it in cancer patients doesn't necessarily mean it caused the cancer. You'd need to show that cancer patients have significantly more exposure than people without cancer, or that the plastic is doing something specific in tumor tissue that it's not doing elsewhere.
Mark
So what happens next?
Mimi
They want to study a larger group of patients and investigate what the microplastics actually do in the body. They're also calling for stricter regulations on plastic production and disposal.
Luke
The regulation call makes sense as a precaution. But the science here is still preliminary. A larger study might confirm the association or might not. And even if they do confirm it, understanding causation will take years of additional research.
Der Puls
- Microplastics were found in 90% of prostate cancer tumor samples — at concentrations two and a half times higher than in the healthy tissue of the same patients.
- The findings arrive against a backdrop of growing alarm: plastic particles have already been detected in nearly every human organ, in blood, and even in placental tissue, yet their role in causing disease has remained poorly understood.
- Prostate cancer affects roughly one in eight American men, making any newly identified risk factor a matter of significant public health urgency.
- Researchers took careful steps to rule out laboratory contamination, replacing standard plastic tools with aluminum and cotton instruments and conducting analysis in dedicated clean rooms.
- The team now plans to investigate whether microplastics trigger chronic inflammation in prostate tissue — a process that could, over time, damage cells and initiate cancerous change.
- Senior researchers are calling for stricter regulatory limits on plastic exposure, even as they acknowledge that a larger study population will be needed to confirm what this pilot study has begun to reveal.
In the quiet accumulation of modern life — the packaging, the cosmetics, the air itself — something invisible has been settling into the human body. Researchers at NYU Langone Health have now found microplastics embedded in the prostate tumors of nine out of ten cancer patients studied, with concentrations in cancerous tissue more than twice those found in healthy cells nearby. It is the first Western study to measure plastic particle buildup directly within prostate tumors, and it raises a question that science is only beginning to ask: whether the materials we have made our world from are quietly reshaping the biology within us.
Researchers at NYU Langone Health have found microplastics embedded in the prostate tumors of nine out of ten cancer patients they studied, with concentrations in cancerous tissue nearly two and a half times higher than in healthy prostate cells from the same patients. Presented at the American Society of Clinical Oncology's Genitourinary Cancers Symposium in late February, the findings mark the first Western study to directly compare plastic particle accumulation in tumors versus noncancerous prostate tissue.
The team analyzed tissue from ten patients undergoing surgical prostate removal. Tumor samples contained roughly forty micrograms of plastic per gram of tissue; healthy tissue held about sixteen. Twelve of the most common plastic molecule types were identified using specialized equipment capable of determining both chemical composition and particle structure.
Plastic fragments reach the body through food packaging, cosmetics, inhalation, and skin absorption. Prior research has documented their presence in nearly every human organ and in blood, but direct evidence linking microplastics to prostate cancer had not existed until now. Prostate cancer is the most common cancer among American men, with approximately one in eight receiving a diagnosis in their lifetime.
Lead author Stacy Loeb described the findings as meaningful evidence that microplastic exposure may function as a prostate cancer risk factor. To guard against contamination, the team replaced standard laboratory plastics with aluminum and cotton tools and conducted all analysis in dedicated clean rooms.
Senior author Vittorio Albergamo called for stricter regulatory controls on plastic exposure and outlined the team's next steps: investigating whether accumulated microplastics provoke an inflammatory response in prostate tissue that, over time, could damage cells and trigger the genetic changes underlying cancer. A larger patient population will be needed to confirm the results. The research was funded by the U.S. Department of Defense.
Researchers at NYU Langone Health have found microplastics embedded in the prostate tumors of nine out of ten cancer patients they studied, with concentrations nearly two and a half times higher in cancerous tissue than in healthy prostate cells nearby. The discovery, presented at the American Society of Clinical Oncology's Genitourinary Cancers Symposium in late February, marks the first Western study to directly measure plastic particle accumulation in prostate tumors and compare it to buildup in noncancerous prostate tissue.
The team analyzed tissue samples from ten patients undergoing surgical removal of the prostate. When they examined tumor samples, they found plastic particles in nine of them. In benign prostate tissue from the same patients, plastic appeared in seven of ten samples. The difference in concentration was striking: cancerous tissue contained roughly forty micrograms of plastic per gram of tissue, while healthy tissue held about sixteen micrograms per gram. The researchers identified twelve of the most common types of plastic molecules in the samples, using specialized equipment to determine both the chemical composition and structure of the particles.
Plastic fragments enter the human body through multiple routes. Food packaging, cosmetics, and other consumer products break down into smaller pieces when heated, used repeatedly, or chemically treated. People inhale microplastics from the air and absorb them through the skin. Previous research has documented these particles in nearly every human organ, in blood, and even in placental tissue. Yet the mechanisms by which microplastics might harm health have remained largely unknown. While earlier studies suggested links between plastic exposure and conditions like heart disease and dementia, direct evidence connecting microplastics to prostate cancer did not exist until now.
Prostate cancer is the most common cancer among American men. According to the Centers for Disease Control and Prevention, roughly one in eight men in the United States will receive a prostate cancer diagnosis at some point in their lifetime. The American Cancer Society identifies it as the leading cancer diagnosis in the male population, making any new understanding of its causes potentially significant for public health.
Stacy Loeb, the study's lead author and a professor in the urology and population health departments at NYU Grossman School of Medicine, described the findings as providing important evidence that microplastic exposure may function as a risk factor for prostate cancer development. To ensure the samples were not contaminated by plastic from laboratory equipment itself, the research team replaced standard tools with instruments made of aluminum, cotton, and other nonplastic materials. They processed all samples in specialized clean rooms designed specifically for microplastic analysis.
Vittorio Albergamo, the study's senior author and an assistant professor in the Department of Pediatrics at NYU Grossman School of Medicine, emphasized that the results underscore the need for stricter regulatory controls on plastic exposure, given how ubiquitous these materials have become in the environment. The team plans to investigate what happens when microplastics accumulate in tissue and how they might trigger cancer development. One hypothesis they intend to explore is that plastic particles may provoke an excessive inflammatory response in prostate tissue, which over time could damage cells and cause the genetic changes that lead to cancer formation.
Albergamo cautioned that a larger patient population will be necessary to confirm the study's findings. The research was funded by the U.S. Department of Defense. The work involved more than a dozen researchers from NYU Langone, along with a collaborator from Northwell Health in New York City. The next phase of investigation will focus on understanding the biological mechanisms by which microplastics might contribute to cancer, a question that remains open and urgent.
Bemerkenswerte Zitate
Our pilot study provides important evidence that microplastic exposure may be a risk factor for prostate cancer.— Stacy Loeb, MD, study lead author
Our findings highlight the need for stricter regulatory measures to limit the public's exposure to these substances, which are everywhere in the environment.— Vittorio Albergamo, PhD, study senior author
Möchten Sie die ganze Geschichte?
Das Original lesen bei News-Medical.net ↗
Science & Space